Recently, Hebei Province People's Government of Hebei Province, considered by the Science and Technology Award 2010 assessment results, the company national second-class materials hydroxypropyl-β-CD project of Hebei Province Science and Technology Progress Award, this is a class of drugs in 2008 the State butylphthalide project since the raw materials and soft capsules, the second award.

developed by the National Institute of Pharmaceutical Research Group, two types of materials hydroxypropyl-β-cyclodextrin is an internationally advanced one pharmaceutical carrier, with enhanced drug solubility, enhanced drug stability, reduce drug toxicity, improve drug availability, and other fine performance. In odd company after years of technological breakthroughs, not only to achieve the industrialization of the product, but also became the only one with two levels of oral and injectable grade production of the symbol of the manufacturers.

as hydroxypropyl-β-cyclodextrin difficult process technology, features high quality standards, so developers pharmaceutical grade hydroxypropyl-β-ring dextrin has been a bottleneck in China's pharmaceutical industry. In the odd company through continuous process innovation, not only to achieve the industrialization of the product, breaking the monopoly of foreign technology, and hydroxypropyl-β-cyclodextrin β-cyclodextrin products, propylene glycol and heavy metal residues far well below the European Pharmacopoeia control targets, particularly the degree of substitution of products range is more reasonable than the scope of the European Pharmacopoeia, to ensure maximum stability of the molecular inclusion. At present the company's oral odd hydroxypropyl-β-cyclodextrin-class quality standards has become the 2010 version of the National Pharmacopoeia standards.

hydroxypropyl-β-cyclodextrin not only for the successful development of a number of pharmaceutical manufacturers in China provides a good source of materials, greatly reducing the import of the materials, and Relying on the materials in the Church developed a series of follow-up to build a new variety of formulations of insoluble drugs in our country's first technology platform will greatly contribute to the Group's new drug formulations and the State Key Laboratory of construction materials, to improve the development of new formulations far-reaching significance.